Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Link

Showing results (641-650 of 673) with videos related to

Pageof 68
Sort By:
Leukemia & Lymphoma|May 11, 2002
Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: further follow-up from the original randomised study to assess engraftmentP D Kottaridis, K Peggs, N Schmitz, et al.
Klinische Wochenschrift|October 15, 1982
[Bone marrow transplantation in patients with leukemia]K Wilms, H Link, P Meyer, et al.
Bone Marrow Transplantation|June 19, 1998
Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CMLT Fischer, A Neubauer, J Mohm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphomaT J Smith, B E Hillner, N Schmitz, et al.
Annals of Hematology|September 19, 2003
Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society)H Link, A Böhme, O A Cornely, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 27, 2011
A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancerA Schmittel, M Sebastian, L Fischer von Weikersthal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
British Journal of Haematology|December 1, 1996
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)A Gratwohl, J Hermans, A van Biezen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracilMarko Kornmann, Wolfgang Schwabe, Silvia Sander, et al.
Pageof 68

Showing results (641-650 of 673) with videos related to

Sort By:
Pageof 68
Leukemia & Lymphoma|May 11, 2002
Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: further follow-up from the original randomised study to assess engraftmentP D Kottaridis, K Peggs, N Schmitz, et al.
Klinische Wochenschrift|October 15, 1982
[Bone marrow transplantation in patients with leukemia]K Wilms, H Link, P Meyer, et al.
Bone Marrow Transplantation|June 19, 1998
Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CMLT Fischer, A Neubauer, J Mohm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphomaT J Smith, B E Hillner, N Schmitz, et al.
Annals of Hematology|September 19, 2003
Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society)H Link, A Böhme, O A Cornely, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 27, 2011
A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancerA Schmittel, M Sebastian, L Fischer von Weikersthal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
British Journal of Haematology|December 1, 1996
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)A Gratwohl, J Hermans, A van Biezen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracilMarko Kornmann, Wolfgang Schwabe, Silvia Sander, et al.
Pageof 68